Organon & (OGN) - 2025 Q4 - Earnings Call Transcript
Organon & Organon & (US:OGN)2026-02-12 14:32
Financials
Slide

Organon (NYSE:OGN) Q4 2025 Earnings call February 12, 2026 08:30 AM ET Company ParticipantsCarrie Cox - Board ChairJennifer Halchak - VP of Investor RelationsJoe Morrissey - Interim CEOJuan Camilo Arjona Ferreira - Head of R&DMatt Walsh - CFOMike Nedelcovych - Director of Equity ResearchPavan Patel - Associate, Biotechnology and Pharmaceuticals Equity ResearchUmer Raffat - Senior Managing DirectorConference Call ParticipantsEthan Brown - Equity Research AnalystTerence Flynn - Equity Research AnalystNone - A ...